Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects

Published:2018-06-04 Issue:2 Volume:48 Page:206-218
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sunwoo J.¹^ORCID,Oh J.¹^ORCID,Moon S. J.²,Ji S. C.¹,Lee S. H.¹,Yu K.-S.¹,Kim H. S.³,Lee A.³,Jang I.-J.¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics; Seoul National University College of Medicine and Hospital; Seoul Korea

2. Center for Clinical Pharmacology; Biomedical Research Institute; Chonbuk National University Hospital; Jeonju-so Korea

3. Daewoong Pharmaceutical Co., Ltd.; Yongin Korea

Funder

Daewoong Pharmaceutical Company

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14818/fullpdf

Reference19 articles.

1. The rationale of acid suppression in the treatment of acid-related disease;Mohamed;Aliment Pharmacol Ther,1994

2. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects;Jenkins;Aliment Pharmacol Ther,2015

3. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease;Vandenplas;J Pediatr Gastroenterol Nutr,2002

4. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease;DeVault;Am J Gastroenterol,2005

5. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease;Cicala;World J Gastroenterol,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers;CPT: Pharmacometrics & Systems Pharmacology;2024-09-13

2. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

3. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

4. Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism;ACS Omega;2024-08-23

5. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3